Article

Glaucoma surgery techniques compared in large-scale Medicare patient study

The claims records of 14,491 Medicare beneficiaries with glaucoma who were treated with an incisional surgery, either primary trabeculectomy, trabeculectomy in the presence of scarring from previous ocular surgery or trauma, or implantation of a glaucoma drainage device between 1994 and 2003 were evaluated.

San Francisco-The claims records of 14,491 Medicare beneficiaries with glaucoma who were treated with an incisional surgery, either primary trabeculectomy (PT), trabeculectomy in the presence of scarring from previous ocular surgery or trauma (TS), or implantation of a glaucoma drainage device (GDD) between 1994 and 2003 were evaluated by Frank A. Sloan, PhD, and colleagues.

It was found that although adverse outcomes were uncommon for all three options, rates of severe outcomes, less severe outcomes, and progression to low vision or blindness were higher for individuals who received GDD than for those who received PT or TS.

Each surgical technique was designed to improve drainage of fluid from the eye to reduce IOP. In both PT and TS a small portion of the trabecular meshwork is removed to increase fluid flow, and in GDD a tiny implanted shunt is used to bypass the trabecular meshwork and redirect fluid flow. It was stated by some studies that GDD performed earlier in complicated glaucoma might provide benefit with fewer outcomes, which is why this study compared GDD, PT, and TS.

Study patients were at least 68 years of age but not older than 96 during the time of evaluation. Study population was diverse, however, the patients treated with GDD were disproportionately African-American, a group at higher risk than other ethnicities of developing glaucoma-related blindness.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.